Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Teladoc launches 'myStrength Complete' mental health service » 08:27
05/11/21
05/11
08:27
05/11/21
08:27
TDOC

Teladoc

$141.07 /

-9.98 (-6.61%)

Teladoc Health announced…

Teladoc Health announced the launch of myStrength Complete, an integrated mental health service providing personalized, targeted care to consumers in a single, comprehensive experience. The announcement comes as more than half of people with mental health concerns report that they do not know where to start when getting care, highlighting the importance of the digital front door myStrength Complete will provide.

ShowHide Related Items >><<
TDOC Teladoc
$141.07 /

-9.98 (-6.61%)

TDOC Teladoc
$141.07 /

-9.98 (-6.61%)

05/10/21 Truist
Teladoc price target lowered to $206 from $275 at Truist
05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Credit Suisse
Teladoc's loss of PepsiCo contract 'old news,' says Credit Suisse
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
TDOC Teladoc
$141.07 /

-9.98 (-6.61%)

TDOC Teladoc
$141.07 /

-9.98 (-6.61%)

TDOC Teladoc
$141.07 /

-9.98 (-6.61%)

TDOC Teladoc
$141.07 /

-9.98 (-6.61%)

Monday
Recommendations
Teladoc price target lowered to $206 from $275 at Truist » 07:55
05/10/21
05/10
07:55
05/10/21
07:55
TDOC

Teladoc

$151.01 /

-0.93 (-0.61%)

Truist analyst Sandy…

Truist analyst Sandy Draper lowered the firm's price target on Teladoc to $206 from $275 but keeps a Buy rating on the shares. The company reported "strong" Q1 results and looks to be on a path to exceed $5B in revenue by 2025, the analyst tells investors in a research note, though he reduces his price target to reflect the lower multiples of comparable high growth companies that have experienced multiple compression over the past several months.

ShowHide Related Items >><<
TDOC Teladoc
$151.01 /

-0.93 (-0.61%)

TDOC Teladoc
$151.01 /

-0.93 (-0.61%)

05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Credit Suisse
Teladoc's loss of PepsiCo contract 'old news,' says Credit Suisse
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
04/29/21 KeyBanc
Teladoc price target lowered to $220 from $270 at KeyBanc
TDOC Teladoc
$151.01 /

-0.93 (-0.61%)

TDOC Teladoc
$151.01 /

-0.93 (-0.61%)

TDOC Teladoc
$151.01 /

-0.93 (-0.61%)

TDOC Teladoc
$151.01 /

-0.93 (-0.61%)

Conference/Events
Teladoc management to meet virtually with Truist » 04:55
05/10/21
05/10
04:55
05/10/21
04:55
TDOC

Teladoc

$151.01 /

-0.93 (-0.61%)

Virtual Meeting to be…

Virtual Meeting to be held on May 10 hosted by Truist.

ShowHide Related Items >><<
TDOC Teladoc
$151.01 /

-0.93 (-0.61%)

TDOC Teladoc
$151.01 /

-0.93 (-0.61%)

05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Credit Suisse
Teladoc's loss of PepsiCo contract 'old news,' says Credit Suisse
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
04/29/21 KeyBanc
Teladoc price target lowered to $220 from $270 at KeyBanc
TDOC Teladoc
$151.01 /

-0.93 (-0.61%)

TDOC Teladoc
$151.01 /

-0.93 (-0.61%)

TDOC Teladoc
$151.01 /

-0.93 (-0.61%)

TDOC Teladoc
$151.01 /

-0.93 (-0.61%)

Friday
Conference/Events
Teladoc management to meet virtually with Truist » 11:28
05/07/21
05/07
11:28
05/07/21
11:28
TDOC

Teladoc

$155.08 /

+3.14 (+2.07%)

Virtual Meeting to be…

Virtual Meeting to be held on May 10 hosted by Truist.

ShowHide Related Items >><<
TDOC Teladoc
$155.08 /

+3.14 (+2.07%)

TDOC Teladoc
$155.08 /

+3.14 (+2.07%)

05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Credit Suisse
Teladoc's loss of PepsiCo contract 'old news,' says Credit Suisse
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
04/29/21 KeyBanc
Teladoc price target lowered to $220 from $270 at KeyBanc
TDOC Teladoc
$155.08 /

+3.14 (+2.07%)

TDOC Teladoc
$155.08 /

+3.14 (+2.07%)

TDOC Teladoc
$155.08 /

+3.14 (+2.07%)

TDOC Teladoc
$155.08 /

+3.14 (+2.07%)

Over a week ago
Options
Unusually active option classes on open May 4th » 09:40
05/04/21
05/04
09:40
05/04/21
09:40
UNVR

Univar

/

+

, YUM

Yum! Brands

/

+

, ATOS

Atossa Therapeutics

/

+

, PFE

Pfizer

/

+

, RKT

Rocket Companies

/

+

, CLF

Cleveland-Cliffs

/

+

, TDOC

Teladoc

/

+

, TWTR

Twitter

/

+

, X

U.S. Steel

/

+

, SQQQ

ProShares UltraPro Short QQQ

/

+

Unusual total active…

Unusual total active option classes on open include: Univar (UNVR), Yum! Brands (YUM), Atossa Genetics (ATOS), Pfizer (PFE), Rocket Companies (RKT), Cleveland-Cliffs (CLF), Teladoc (TDOC), Twitter (TWTR), US Steel (X), and ProShares UltraPro Short QQQ (SQQQ).

ShowHide Related Items >><<
YUM Yum! Brands
/

+

X U.S. Steel
/

+

UNVR Univar
/

+

TWTR Twitter
/

+

TDOC Teladoc
/

+

RKT Rocket Companies
/

+

PFE Pfizer
/

+

CLF Cleveland-Cliffs
/

+

ATOS Atossa Therapeutics
/

+

UNVR Univar
/

+

03/08/21 BofA
Univar downgraded to Underperform from Buy at BofA
11/06/20 Goldman Sachs
Univar downgraded to Neutral from Buy at Goldman Sachs
YUM Yum! Brands
/

+

04/29/21 BMO Capital
Yum! Brands price target raised to $120 from $105 at BMO Capital
04/29/21 Credit Suisse
Yum! Brands price target raised to $120 from $108 at Credit Suisse
04/29/21 Oppenheimer
Yum! Brands price target raised to $135 from $120 at Oppenheimer
04/29/21 Baird
Yum! Brands price target raised to $130 from $127 at Baird
ATOS Atossa Therapeutics
/

+

09/17/20 Ascendiant
Ascendiant starts Atossa Therapeutics with Buy rating, $7 price target
09/17/20 Ascendiant
Atossa Therapeutics initiated with a Buy at Ascendiant
07/17/20 Maxim
Atossa Therapeutics price target raised to $8 from $4 at Maxim
07/16/20 Maxim
Maxim doubles Atossa price target to $8 on positive COVID data
PFE Pfizer
/

+

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
RKT Rocket Companies
/

+

04/21/21
Fly Intel: Top five analyst downgrades
04/21/21 BofA
Rocket Companies downgraded to Neutral from Buy at BofA
04/05/21 Cowen
Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen
03/26/21 Credit Suisse
Credit Suisse lowers estimates on mortgage originators
CLF Cleveland-Cliffs
/

+

05/04/21 Credit Suisse
Cleveland-Cliffs upgraded to Outperform from Neutral at Credit Suisse
05/04/21 Credit Suisse
Cleveland-Cliffs upgraded to Outperform from Neutral at Credit Suisse
04/30/21 B. Riley
Cleveland-Cliffs price target raised to $33 from $24 at B. Riley
04/26/21 B. Riley
Cleveland-Cliffs price target raised to $24 from $22 at B. Riley
TDOC Teladoc
/

+

05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Credit Suisse
Teladoc's loss of PepsiCo contract 'old news,' says Credit Suisse
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
04/29/21 KeyBanc
Teladoc price target lowered to $220 from $270 at KeyBanc
TWTR Twitter
/

+

05/03/21 BMO Capital
Twitter price target lowered to $65 from $80 at BMO Capital
04/30/21 MKM Partners
Twitter price target lowered to $83 from $95 at MKM Partners
04/30/21 JPMorgan
Twitter earnings selloff a buying opportunity, says JPMorgan
04/30/21 Morgan Stanley
Twitter price target lowered to $62 from $68 at Morgan Stanley
X U.S. Steel
/

+

05/04/21 Credit Suisse
U.S. Steel upgraded to Outperform from Underperform at Credit Suisse
04/09/21 Goldman Sachs
U.S. Steel initiated with a Neutral at Goldman Sachs
03/15/21
Fly Intel: Top five analyst downgrades
03/15/21 BMO Capital
U.S. Steel price target raised to $25 from $21 at BMO Capital
SQQQ ProShares UltraPro Short QQQ
/

+

YUM Yum! Brands
/

+

X U.S. Steel
/

+

UNVR Univar
/

+

TWTR Twitter
/

+

TDOC Teladoc
/

+

RKT Rocket Companies
/

+

PFE Pfizer
/

+

CLF Cleveland-Cliffs
/

+

  • 09
    Feb
  • 03
    Feb
  • 06
    Aug
  • 18
    Jun
YUM Yum! Brands
/

+

X U.S. Steel
/

+

TWTR Twitter
/

+

TDOC Teladoc
/

+

RKT Rocket Companies
/

+

PFE Pfizer
/

+

YUM Yum! Brands
/

+

X U.S. Steel
/

+

TWTR Twitter
/

+

TDOC Teladoc
/

+

RKT Rocket Companies
/

+

PFE Pfizer
/

+

CLF Cleveland-Cliffs
/

+

X U.S. Steel
/

+

TWTR Twitter
/

+

TDOC Teladoc
/

+

SQQQ ProShares UltraPro Short QQQ
/

+

RKT Rocket Companies
/

+

PFE Pfizer
/

+

CLF Cleveland-Cliffs
/

+

ATOS Atossa Therapeutics
/

+

Recommendations
Teladoc closed down 5% on three year old 'news,' says Piper Sandler » 05:47
05/04/21
05/04
05:47
05/04/21
05:47
TDOC

Teladoc

/

+

, AMWL

Amwell

/

+

, PEP

PepsiCo

/

+

, ANTM

Anthem

/

+

Piper Sandler analyst…

Piper Sandler analyst Sean Wieland says shares of Teladoc Health (TDOC) closed down 5% yesterday on a misinterpreted article from the Wall Street Journal. The article quoted Erik Sossa on his decision to migrate PepsiCo's (PRP) telehealth contract from Teladoc to Amwell (AMWL), Wieland tells investors in a research note. In subsequent reports, this decision was construed as new "news," but it is not, says the analyst. Wieland notes that PepsiCo has been using LiveHealth Online, Anthem's (ANTM) integrated Telehealth solution powered by Amwell, since 2018. Teladoc lost over $1.5B of market capitalization on three year old "news" that has no bearing on current fundamental or competitive dynamics, contends Wieland. As such, he would be buyers of the stock on the selloff. Wieland reiterates an Overweight rating on Teladoc with a $291 price target.

ShowHide Related Items >><<
TDOC Teladoc
/

+

PEP PepsiCo
/

+

ANTM Anthem
/

+

AMWL Amwell
/

+

TDOC Teladoc
/

+

05/03/21 Credit Suisse
Teladoc's loss of PepsiCo contract 'old news,' says Credit Suisse
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
04/29/21 KeyBanc
Teladoc price target lowered to $220 from $270 at KeyBanc
04/29/21 Craig-Hallum
Teladoc price target lowered to $202 from $220 at Craig-Hallum
AMWL Amwell
/

+

04/26/21 Piper Sandler
Piper Sandler 'incrementally bullish' on Amwell, Teladoc, 1Life
04/16/21 KeyBanc
Amwell initiated with a Sector Weight at KeyBanc
04/15/21 Needham
Needham starts Amwell at Hold, sees limited near-term upside
PEP PepsiCo
/

+

04/21/21
Fly Intel: Top five analyst upgrades
04/21/21 UBS
PepsiCo upgraded to Buy from Neutral at UBS
04/21/21 UBS
PepsiCo upgraded to Buy from Neutral at UBS
ANTM Anthem
/

+

05/03/21 Mizuho
Anthem price target raised to $380 from $320 at Mizuho
04/28/21 Morgan Stanley
Centene didn't meet 'high bar' set by peers, says Morgan Stanley
04/22/21 Stephens
Anthem price target raised to $430 from $395 at Stephens
04/22/21 Credit Suisse
Anthem price target raised to $725 from $382 at Credit Suisse
TDOC Teladoc
/

+

PEP PepsiCo
/

+

ANTM Anthem
/

+

AMWL Amwell
/

+

  • 15
    Jan
  • 17
    Sep
TDOC Teladoc
/

+

PEP PepsiCo
/

+

ANTM Anthem
/

+

TDOC Teladoc
/

+

PEP PepsiCo
/

+

ANTM Anthem
/

+

AMWL Amwell
/

+

TDOC Teladoc
/

+

PEP PepsiCo
/

+

ANTM Anthem
/

+

AMWL Amwell
/

+

Recommendations
Teladoc's loss of PepsiCo contract 'old news,' says Credit Suisse » 16:53
05/03/21
05/03
16:53
05/03/21
16:53
TDOC

Teladoc

$163.21 /

-9.225 (-5.35%)

Credit Suisse analyst…

Credit Suisse analyst Jailendra Singh maintained an Outperform rating and $264 price target on Teladoc following weakness in the stock due to the "confusion around an old contract loss" of PepsiCo, which the analyst noted ended back in 2020, if not earlier.

ShowHide Related Items >><<
TDOC Teladoc
$163.21 /

-9.225 (-5.35%)

TDOC Teladoc
$163.21 /

-9.225 (-5.35%)

05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
04/29/21 KeyBanc
Teladoc price target lowered to $220 from $270 at KeyBanc
04/29/21 Craig-Hallum
Teladoc price target lowered to $202 from $220 at Craig-Hallum
04/29/21 Canaccord
Teladoc price target lowered to $295 from $330 at Canaccord
TDOC Teladoc
$163.21 /

-9.225 (-5.35%)

TDOC Teladoc
$163.21 /

-9.225 (-5.35%)

TDOC Teladoc
$163.21 /

-9.225 (-5.35%)

TDOC Teladoc
$163.21 /

-9.225 (-5.35%)

Recommendations
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald » 14:53
05/03/21
05/03
14:53
05/03/21
14:53
TDOC

Teladoc

$163.65 /

-8.78 (-5.09%)

, AMWL

Amwell

$14.59 /

-0.8 (-5.20%)

, PEP

PepsiCo

$146.05 /

+1.83 (+1.27%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Steven Halper noted that The Wall Street Journal reported in an article on digital health startups that the former head of benefits at PepsiCo (PEP) said that "telehealth is kind of a commodity" and the same report pointed out that Pepsi switched from Teladoc (TDOC) to Live Health Online, which Halper said is "essentially owned" by Amwell (AMWL). While virtual health continues to see strong adoption, Halper views Teladoc shares as expensive at current levels and he keeps a Neutral rating on the stock with a $210 price target.

ShowHide Related Items >><<
TDOC Teladoc
$163.65 /

-8.78 (-5.09%)

PEP PepsiCo
$146.05 /

+1.83 (+1.27%)

AMWL Amwell
$14.59 /

-0.8 (-5.20%)

TDOC Teladoc
$163.65 /

-8.78 (-5.09%)

04/29/21 KeyBanc
Teladoc price target lowered to $220 from $270 at KeyBanc
04/29/21 Craig-Hallum
Teladoc price target lowered to $202 from $220 at Craig-Hallum
04/29/21 Canaccord
Teladoc price target lowered to $295 from $330 at Canaccord
04/29/21 BTIG
Teladoc price target lowered to $300 from $330 at BTIG
AMWL Amwell
$14.59 /

-0.8 (-5.20%)

04/26/21 Piper Sandler
Piper Sandler 'incrementally bullish' on Amwell, Teladoc, 1Life
04/16/21 KeyBanc
Amwell initiated with a Sector Weight at KeyBanc
04/15/21 Needham
Needham starts Amwell at Hold, sees limited near-term upside
04/15/21 Needham
Amwell initiated with a Hold at Needham
PEP PepsiCo
$146.05 /

+1.83 (+1.27%)

04/21/21
Fly Intel: Top five analyst upgrades
04/21/21 UBS
PepsiCo upgraded to Buy from Neutral at UBS
04/21/21 UBS
PepsiCo upgraded to Buy from Neutral at UBS
04/16/21 Deutsche Bank
PepsiCo price target raised to $147 from $145 at Deutsche Bank
TDOC Teladoc
$163.65 /

-8.78 (-5.09%)

PEP PepsiCo
$146.05 /

+1.83 (+1.27%)

AMWL Amwell
$14.59 /

-0.8 (-5.20%)

  • 15
    Jan
  • 17
    Sep
TDOC Teladoc
$163.65 /

-8.78 (-5.09%)

PEP PepsiCo
$146.05 /

+1.83 (+1.27%)

TDOC Teladoc
$163.65 /

-8.78 (-5.09%)

PEP PepsiCo
$146.05 /

+1.83 (+1.27%)

AMWL Amwell
$14.59 /

-0.8 (-5.20%)

TDOC Teladoc
$163.65 /

-8.78 (-5.09%)

PEP PepsiCo
$146.05 /

+1.83 (+1.27%)

AMWL Amwell
$14.59 /

-0.8 (-5.20%)

Periodicals
PepsiCo stops using Teladoc for telemedicine services, WSJ reports » 14:52
05/03/21
05/03
14:52
05/03/21
14:52
PEP

PepsiCo

$146.05 /

+1.83 (+1.27%)

, TDOC

Teladoc

$163.60 /

-8.83 (-5.12%)

Though digital-health…

Though digital-health startups have boomed during the COVID-19 pandemic, with certain corporate-benefits executives are saying that the explosion of activity in the sector has spawned a glut of startups pitching redundant or overpriced services, the Wall Street Journal's Rolfe Winkler reports. For example, Erik Sossa, who recently retired as head of benefits at PepsiCo (PEP), said that digital-health services work best when connected to a company's existing health plan so doctors can view patient health histories, which is one reason Pepsi stopped using Teladoc (TDOC) for telemedicine services, the author says. "Telemedicine is a fantastic medium, but if it's just late-night urgent care, it's kind of a commodity," Sossa said. A Teladoc spokesman told the Journal that its work with Pepsi has evolved over time, but declined to provide any details on the matter. Reference Link

ShowHide Related Items >><<
TDOC Teladoc
$163.60 /

-8.83 (-5.12%)

PEP PepsiCo
$146.05 /

+1.83 (+1.27%)

PEP PepsiCo
$146.05 /

+1.83 (+1.27%)

04/21/21
Fly Intel: Top five analyst upgrades
04/21/21 UBS
PepsiCo upgraded to Buy from Neutral at UBS
04/21/21 UBS
PepsiCo upgraded to Buy from Neutral at UBS
04/16/21 Deutsche Bank
PepsiCo price target raised to $147 from $145 at Deutsche Bank
TDOC Teladoc
$163.60 /

-8.83 (-5.12%)

04/29/21 KeyBanc
Teladoc price target lowered to $220 from $270 at KeyBanc
04/29/21 Craig-Hallum
Teladoc price target lowered to $202 from $220 at Craig-Hallum
04/29/21 Canaccord
Teladoc price target lowered to $295 from $330 at Canaccord
04/29/21 BTIG
Teladoc price target lowered to $300 from $330 at BTIG
TDOC Teladoc
$163.60 /

-8.83 (-5.12%)

PEP PepsiCo
$146.05 /

+1.83 (+1.27%)

PEP PepsiCo
$146.05 /

+1.83 (+1.27%)

TDOC Teladoc
$163.60 /

-8.83 (-5.12%)

PEP PepsiCo
$146.05 /

+1.83 (+1.27%)

TDOC Teladoc
$163.60 /

-8.83 (-5.12%)

PEP PepsiCo
$146.05 /

+1.83 (+1.27%)

Recommendations
Teladoc price target lowered to $220 from $270 at KeyBanc » 09:29
04/29/21
04/29
09:29
04/29/21
09:29
TDOC

Teladoc

$186.31 /

-3.49 (-1.84%)

KeyBanc analyst Donald…

KeyBanc analyst Donald Hooker lowered the firm's price target on Teladoc to $220 from $270 and keeps an Overweight rating on the shares after the company reported "strong" Q1 organic revenue growth of 67%. By his models, Teladoc remains on track to grow its revenues by 35%-plus in 2021 and 30%-plus in 2022, which should be comforting to those concerned about a potential post-COVID-19 deceleration in telehealth adoption and utilization. That said, Hooker is reducing his price target solely due to the negative impact of rising interest rates on SaaS valuations, but continues to see material upside potential in the shares.

ShowHide Related Items >><<
TDOC Teladoc
$186.31 /

-3.49 (-1.84%)

TDOC Teladoc
$186.31 /

-3.49 (-1.84%)

04/29/21 Craig-Hallum
Teladoc price target lowered to $202 from $220 at Craig-Hallum
04/29/21 Canaccord
Teladoc price target lowered to $295 from $330 at Canaccord
04/29/21 BTIG
Teladoc price target lowered to $300 from $330 at BTIG
04/29/21 Oppenheimer
Teladoc price target lowered to $250 from $270 at Oppenheimer
TDOC Teladoc
$186.31 /

-3.49 (-1.84%)

TDOC Teladoc
$186.31 /

-3.49 (-1.84%)

TDOC Teladoc
$186.31 /

-3.49 (-1.84%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.